25.87
price down icon2.08%   -0.55
after-market アフターアワーズ: 25.80 -0.07 -0.27%
loading
前日終値:
$26.42
開ける:
$26.61
24時間の取引高:
351.98K
Relative Volume:
0.81
時価総額:
$1.10B
収益:
$720.53M
当期純損益:
$79.23M
株価収益率:
15.54
EPS:
1.6648
ネットキャッシュフロー:
$132.94M
1週間 パフォーマンス:
-2.82%
1か月 パフォーマンス:
+8.02%
6か月 パフォーマンス:
+18.62%
1年 パフォーマンス:
+11.41%
1日の値動き範囲:
Value
$25.52
$26.61
1週間の範囲:
Value
$25.52
$27.10
52週間の値動き範囲:
Value
$16.64
$29.52

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Name
名前
Amphastar Pharmaceuticals Inc
Name
セクター
Healthcare (1052)
Name
電話
909-980-9484
Name
住所
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Name
職員
1,976
Name
Twitter
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
AMPH's Discussions on Twitter

Compare AMPH vs TAK, TEVA, HLN, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AMPH icon
AMPH
Amphastar Pharmaceuticals Inc
25.87 1.10B 720.53M 79.23M 132.94M 1.6648
TAK icon
TAK
Takeda Pharmaceutical Co Adr
19.67 62.84B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
41.50 48.40B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
10.13 44.55B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
79.38 32.80B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
533.12 22.87B 3.17B 1.29B 1.01B 27.09

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-06-29 ダウングレード BofA Securities Neutral → Underperform
2026-05-14 ダウングレード Wells Fargo Overweight → Equal Weight
2026-05-08 ダウングレード Needham Buy → Hold
2026-04-21 ダウングレード Jefferies Buy → Hold
2025-12-09 開始されました Barclays Equal Weight
2025-08-12 アップグレード Needham Hold → Buy
2025-05-12 ダウングレード JP Morgan Overweight → Neutral
2025-02-04 ダウングレード Piper Sandler Overweight → Neutral
2024-11-22 開始されました Wells Fargo Equal Weight
2024-03-05 開始されました JP Morgan Overweight
2023-11-17 開始されました BofA Securities Neutral
2023-07-25 再開されました Jefferies Buy
2022-10-21 再開されました Jefferies Buy
2022-07-29 開始されました CapitalOne Overweight
2022-01-07 アップグレード Piper Sandler Neutral → Overweight
2021-01-08 ダウングレード Wells Fargo Overweight → Equal Weight
2020-10-05 アップグレード Northland Capital Market Perform → Outperform
2020-05-01 開始されました Northland Capital Outperform
2019-03-13 ダウングレード Needham Buy → Hold
2019-03-13 ダウングレード Piper Jaffray Overweight → Neutral
2018-08-10 繰り返されました Needham Buy
2018-03-13 繰り返されました Needham Buy
2017-12-01 繰り返されました Needham Buy
2017-11-09 ダウングレード Raymond James Outperform → Mkt Perform
2017-09-27 繰り返されました Needham Buy
2017-03-14 ダウングレード Raymond James Strong Buy → Outperform
2016-08-09 繰り返されました Needham Buy
2016-05-10 繰り返されました Needham Buy
2016-02-19 開始されました Wells Fargo Outperform
2015-06-19 繰り返されました Needham Buy
2015-06-03 開始されました Raymond James Strong Buy
2014-07-21 開始されました Needham Buy
すべてを表示

Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース

pulisher
Oct 06, 2026

Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? - Zacks Investment Research

Oct 06, 2026
pulisher
Oct 06, 2026

Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? - Yahoo Finance

Oct 06, 2026
pulisher
Oct 03, 2026

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating Raised to Strong-Buy at Wall Street Zen - MarketBeat

Oct 03, 2026
pulisher
Oct 01, 2026

AMPH5896384 Bond Profile: Coupon and Redemption - tradingview.com

Oct 01, 2026
pulisher
Oct 01, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada

Oct 01, 2026
pulisher
Sep 30, 2026

A Look at Amphastar Pharmaceuticals Inc (AMPH) After 3.3% Decline -- GF Value $36.36 vs Price $25.81 - GuruFocus

Sep 30, 2026
pulisher
Sep 30, 2026

Amphastar: 2 Years Since My Last Hold Call, I Remain On Sidelines (NASDAQ:AMPH) - Seeking Alpha

Sep 30, 2026
pulisher
Sep 30, 2026

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Reduce" from Analysts - MarketBeat

Sep 30, 2026
pulisher
Sep 30, 2026

Bank of America Corp DE Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Sep 30, 2026
pulisher
Sep 28, 2026

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Up 5.7%What's Next? - MarketBeat

Sep 28, 2026
pulisher
Sep 24, 2026

Is It Too Late to Buy Amphastar Pharmaceuticals Inc (AMPH) After 5.2% Rally? GF Value Says Undervalued - GuruFocus

Sep 24, 2026
pulisher
Sep 24, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo Finance

Sep 24, 2026
pulisher
Sep 23, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 23, 2026

Insider Selling: Amphastar Pharmaceuticals (NASDAQ:AMPH) CFO Sells 4,139 Shares - MarketBeat

Sep 23, 2026
pulisher
Sep 23, 2026

At $25 a share, Amphastar Pharmaceuticals (AMPH) CFO William Peters sold 4,139 shares. - Stock Titan

Sep 23, 2026
pulisher
Sep 21, 2026

Amphastar (NASDAQ: AMPH) exec plans 4,139-share Rule 144 sale - Stock Titan

Sep 21, 2026
pulisher
Sep 17, 2026

Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group - Yahoo Finance

Sep 17, 2026
pulisher
Sep 12, 2026

Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

Sep 12, 2026
pulisher
Sep 07, 2026

Legal & General Group Plc Makes New $1.58 Million Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Sep 07, 2026
pulisher
Sep 06, 2026

Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued? - Yahoo Finance

Sep 06, 2026
pulisher
Sep 06, 2026

Bank of New York Mellon Corp Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Sep 06, 2026
pulisher
Sep 05, 2026

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat

Sep 05, 2026
pulisher
Sep 05, 2026

Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting - Yahoo Finance

Sep 05, 2026
pulisher
Sep 03, 2026

Rong Zhou Sells 3,187 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat

Sep 03, 2026
pulisher
Sep 03, 2026

Insider sells 3,187 shares at Amphastar (NASDAQ: AMPH) - Stock Titan

Sep 03, 2026
pulisher
Sep 02, 2026

A Look at Amphastar Pharmaceuticals Inc (AMPH) After 3.3% Gain -- GF Value $35.96 vs Price $23.74 - GuruFocus

Sep 02, 2026
pulisher
Sep 02, 2026

Empowered Funds LLC Invests $3.29 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Sep 02, 2026
pulisher
Sep 01, 2026

Amphastar (NASDAQ: AMPH) VP plans Rule 144 stock sale led by 10,000-share option exercise - Stock Titan

Sep 01, 2026
pulisher
Sep 01, 2026

Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference - Stock Titan

Sep 01, 2026
pulisher
Sep 01, 2026

Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference - PR Newswire

Sep 01, 2026
pulisher
Aug 31, 2026

Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris - Yahoo Finance

Aug 31, 2026
pulisher
Aug 31, 2026

Bank of America Corp DE Acquires 46,149 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Aug 31, 2026
pulisher
Aug 29, 2026

Amphastar Pharmaceuticals, Inc. $AMPH Stock Holdings Lifted by Algert Global LLC - marketbeat.com

Aug 29, 2026
pulisher
Aug 28, 2026

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Passes Above 50-Day Moving AverageShould You Sell? - marketbeat.com

Aug 28, 2026
pulisher
Aug 22, 2026

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Eastern Progress

Aug 22, 2026
pulisher
Aug 20, 2026

Amphastar Pharmaceuticals Earnings Call Balances Growth And Risk - TipRanks

Aug 20, 2026
pulisher
Aug 20, 2026

Denali Advisors LLC Has $7.59 Million Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Aug 20, 2026
pulisher
Aug 19, 2026

Amphastar (AMPH) Quarterly Results: EPS Exceeds Its Estimate in Latest Trading; Trading Response: The Stock Ends Up 2.30% on the DayEarnings Weakness Phase - Vinanet

Aug 19, 2026
pulisher
Aug 18, 2026

Amphastar (NASDAQ: AMPH) insider lines up stock sale after option exercise - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

Barclays Issues Positive Forecast for Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price - MarketBeat

Aug 18, 2026
pulisher
Aug 18, 2026

Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating - marketscreener.com

Aug 18, 2026
pulisher
Aug 14, 2026

Is It Too Late to Buy Amphastar Pharmaceuticals Inc (AMPH) After 3.6% Rally? GF Value Says Undervalued - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals - simplywall.st

Aug 14, 2026
pulisher
Aug 14, 2026

Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals - webull.com

Aug 14, 2026
pulisher
Aug 14, 2026

The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance

Aug 14, 2026
pulisher
Aug 13, 2026

Amphastar Pharmaceuticals (AMPH) Director Richard Prins Sells 7, - GuruFocus

Aug 13, 2026
pulisher
Aug 12, 2026

Richard Prins Sells 7,973 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

Amphastar director Richard Prins disposes of shares valued at $161,851 By Investing.com - Investing.com South Africa

Aug 12, 2026
pulisher
Aug 12, 2026

Amphastar director Richard Prins disposes of shares valued at $161,851 - Investing.com

Aug 12, 2026
pulisher
Aug 12, 2026

Amphastar director Richard Prins disposes of shares valued at $161,851 - Investing.com

Aug 12, 2026

Amphastar Pharmaceuticals Inc (AMPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Amphastar Pharmaceuticals Inc (AMPH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
PETERS WILLIAM J
Officer
Sep 21 '26
Proposed Sale
25.00
4,139
103,475
0
Zhou Rong
SENIOR EVP, PRODUCTION CENTER
Sep 16 '26
Sale
23.94
10,000
239,404
169,203
Zhou Rong
SENIOR EVP, PRODUCTION CENTER
Sep 16 '26
Option Exercise
13.35
10,000
133,500
179,203
Zhou Rong
SENIOR EVP, PRODUCTION CENTER
Sep 02 '26
Sale
23.63
3,187
75,306
169,203
Rong Zhou
Vice President
Sep 01 '26
Proposed Sale
22.00
13,187
290,114
0
Floyd Petersen
Director
Aug 18 '26
Proposed Sale
21.00
47,101
989,121
0
PRINS RICHARD K
Director
Aug 11 '26
Sale
20.30
7,973
161,852
29,625
Richard Prins
Director
Aug 11 '26
Proposed Sale
20.31
7,973
161,932
0
PETERS WILLIAM J
CFO, EVP & TREASURER
Aug 07 '26
Option Exercise
19.79
5,053
99,999
181,026
PETERS WILLIAM J
CFO, EVP & TREASURER
Aug 07 '26
Sale
22.48
8,180
183,886
172,846
$27.28
price down icon 5.11%
$3.21
price up icon 0.31%
$50.31
price down icon 1.99%
$23.19
price up icon 0.04%
$36.34
price up icon 0.03%
$38.82
price up icon 2.21%
大文字化:     |  ボリューム (24 時間):